Biblio

Export 1465 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is H  [Clear All Filters]
2023
J. C. Roach, Rapozo, M. K., Hara, J., Glusman, G., Lovejoy, J., Shankle, W. R., and Hood, L., A Remotely Coached Multimodal Lifestyle Intervention for Alzheimer's Disease Ameliorates Functional and Cognitive Outcomes., J Alzheimers Dis, vol. 96, no. 2, pp. 591-607, 2023.
J. C. Roach, Rapozo, M. K., Hara, J., Glusman, G., Lovejoy, J., Shankle, W. R., and Hood, L., A Remotely Coached Multimodal Lifestyle Intervention for Alzheimer's Disease Ameliorates Functional and Cognitive Outcomes., J Alzheimers Dis, vol. 96, no. 2, pp. 591-607, 2023.
F. C. T. van der Heide, Mokhtar, S., Khanna, A., Said, M., Henry, R. M. A., Kroon, A. A., Dagnelie, P. C., Eussen, S. J. P. M., Berendschot, T. T. J. M., Schouten, J. S. A. G., Schram, M. T., van der Kallen, C. J. H., van Greevenbroek, M. M. J., Wesselius, A., Savelberg, H. H. C. M., Schaper, N. C., Webers, C. A. B., and Stehouwer, C. D. A., Retinal Functional and Structural Neural Indices: Potential Biomarkers for the Monitoring of Cerebral Neurodegeneration: The Maastricht Study., J Alzheimers Dis, vol. 93, no. 4, pp. 1471-1483, 2023.
B. Su Mee Hui, Zhi, L. Rui, Retinasamy, T., Arulsamy, A., Law, C. Shing Wei, Shaikh, M. Farooq, and Yeong, K. Yoon, The Role of Interferon-α in Neurodegenerative Diseases: A Systematic Review., J Alzheimers Dis, vol. 94, no. s1, pp. S45-S66, 2023.
X. Wang, Huang, R., Huang, B., and Li, X., S1PR2 Regulates Autophagy Through the AKT/mTOR Pathway to Promote Pathological Damage in Alzheimer's Disease., J Alzheimers Dis, vol. 96, no. 4, pp. 1489-1504, 2023.
X. Wang, Huang, R., Huang, B., and Li, X., S1PR2 Regulates Autophagy Through the AKT/mTOR Pathway to Promote Pathological Damage in Alzheimer's Disease., J Alzheimers Dis, vol. 96, no. 4, pp. 1489-1504, 2023.
M. Pejstrup Agger, Danielsen, E. Rubæk, Carstensen, M. Schultz, N Nguyen, M., Horning, M., Henney, M. Alexander, Jensen, C. Boe Ravn, Baandrup, A. Ohlhues, Kjær, T. Wesenberg, Madsen, K. Hougaard, Miskowiak, K., Petersen, P. Michael, and Høgh, P., Safety, Feasibility, and Potential Clinical Efficacy of 40 Hz Invisible Spectral Flicker versus Placebo in Patients with Mild-to-Moderate Alzheimer's Disease: A Randomized, Placebo-Controlled, Double-Blinded, Pilot Study., J Alzheimers Dis, vol. 92, no. 2, pp. 653-665, 2023.
M. Pejstrup Agger, Danielsen, E. Rubæk, Carstensen, M. Schultz, N Nguyen, M., Horning, M., Henney, M. Alexander, Jensen, C. Boe Ravn, Baandrup, A. Ohlhues, Kjær, T. Wesenberg, Madsen, K. Hougaard, Miskowiak, K., Petersen, P. Michael, and Høgh, P., Safety, Feasibility, and Potential Clinical Efficacy of 40 Hz Invisible Spectral Flicker versus Placebo in Patients with Mild-to-Moderate Alzheimer's Disease: A Randomized, Placebo-Controlled, Double-Blinded, Pilot Study., J Alzheimers Dis, vol. 92, no. 2, pp. 653-665, 2023.
M. Pejstrup Agger, Danielsen, E. Rubæk, Carstensen, M. Schultz, N Nguyen, M., Horning, M., Henney, M. Alexander, Jensen, C. Boe Ravn, Baandrup, A. Ohlhues, Kjær, T. Wesenberg, Madsen, K. Hougaard, Miskowiak, K., Petersen, P. Michael, and Høgh, P., Safety, Feasibility, and Potential Clinical Efficacy of 40 Hz Invisible Spectral Flicker versus Placebo in Patients with Mild-to-Moderate Alzheimer's Disease: A Randomized, Placebo-Controlled, Double-Blinded, Pilot Study., J Alzheimers Dis, vol. 92, no. 2, pp. 653-665, 2023.
G. S. Smith, Kuwabara, H., Yan, H., Nassery, N., Yoon, M., Kamath, V., Kraut, M., Gould, N. F., Savonenko, A., Coughlin, J. M., Lodge, M., Pomper, M. G., Nandi, A., Holt, D., Dannals, R. F., and Leoutsakos, J. M., Serotonin Degeneration and Amyloid-β Deposition in Mild Cognitive Impairment: Relationship to Cognitive Deficits., J Alzheimers Dis, vol. 96, no. 1, pp. 215-227, 2023.
C. Wu, Ma, Y. - H., Hu, H., Zhao, B., and Tan, L., Soluble TREM2, Alzheimer's Disease Pathology, and Risk for Progression of Cerebral Small Vessel Disease: A Longitudinal Study., J Alzheimers Dis, vol. 92, no. 1, pp. 311-322, 2023.
E. Z. Huie, Escudero, A., Saito, N., Harvey, D., Le Nguyen, M. -, Lucot, K. L., LaGrande, J., Mungas, D., DeCarli, C., Lamar, M., Schneider, J. A., Kapasi, A., Rissman, R. A., Teich, A. F., and Dugger, B. N., TDP-43 Pathology in the Setting of Intermediate and High Alzheimer's Disease Neuropathologic Changes: A Preliminary Evaluation Across Ethnoracial Groups., J Alzheimers Dis, vol. 91, no. 4, pp. 1291-1301, 2023.
E. Z. Huie, Escudero, A., Saito, N., Harvey, D., Le Nguyen, M. -, Lucot, K. L., LaGrande, J., Mungas, D., DeCarli, C., Lamar, M., Schneider, J. A., Kapasi, A., Rissman, R. A., Teich, A. F., and Dugger, B. N., TDP-43 Pathology in the Setting of Intermediate and High Alzheimer's Disease Neuropathologic Changes: A Preliminary Evaluation Across Ethnoracial Groups., J Alzheimers Dis, vol. 91, no. 4, pp. 1291-1301, 2023.
S. L. Hartley, Fleming, V., Schworer, E. K., Peven, J., Handen, B. L., Krinsky-McHale, S., Hom, C., Lee, L., Tudorascu, D. L., Laymon, C., Minhas, D., Luo, W., Cohen, A., Zaman, S., Ances, B. M., Mapstone, M., Head, E., Lai, F., H Rosas, D., Klunk, W., and Christian, B., Timing of Alzheimer's Disease by Intellectual Disability Level in Down Syndrome., J Alzheimers Dis, vol. 95, no. 1, pp. 213-225, 2023.
S. L. Hartley, Fleming, V., Schworer, E. K., Peven, J., Handen, B. L., Krinsky-McHale, S., Hom, C., Lee, L., Tudorascu, D. L., Laymon, C., Minhas, D., Luo, W., Cohen, A., Zaman, S., Ances, B. M., Mapstone, M., Head, E., Lai, F., H Rosas, D., Klunk, W., and Christian, B., Timing of Alzheimer's Disease by Intellectual Disability Level in Down Syndrome., J Alzheimers Dis, vol. 95, no. 1, pp. 213-225, 2023.
S. L. Hartley, Fleming, V., Schworer, E. K., Peven, J., Handen, B. L., Krinsky-McHale, S., Hom, C., Lee, L., Tudorascu, D. L., Laymon, C., Minhas, D., Luo, W., Cohen, A., Zaman, S., Ances, B. M., Mapstone, M., Head, E., Lai, F., H Rosas, D., Klunk, W., and Christian, B., Timing of Alzheimer's Disease by Intellectual Disability Level in Down Syndrome., J Alzheimers Dis, vol. 95, no. 1, pp. 213-225, 2023.
S. L. Hartley, Fleming, V., Schworer, E. K., Peven, J., Handen, B. L., Krinsky-McHale, S., Hom, C., Lee, L., Tudorascu, D. L., Laymon, C., Minhas, D., Luo, W., Cohen, A., Zaman, S., Ances, B. M., Mapstone, M., Head, E., Lai, F., H Rosas, D., Klunk, W., and Christian, B., Timing of Alzheimer's Disease by Intellectual Disability Level in Down Syndrome., J Alzheimers Dis, vol. 95, no. 1, pp. 213-225, 2023.
H. Shinagawa, Ohuchi, K., Goto, Y., Hashimoto, K., Kijima, H., Maekawa, S., Kurita, H., and Inden, M., Vacuolar Protein-Sorting Proteins Are Reduced Even Before Cognitive Decline in a Mouse Model of Alzheimer's Disease., J Alzheimers Dis, vol. 96, no. 3, pp. 1011-1017, 2023.
E. Stallard, Kociolek, A., Jin, Z., Ryu, H., Lee, S., Cosentino, S., Zhu, C., Gu, Y., Fernandez, K., Hernandez, M., Kinosian, B., and Stern, Y., Validation of a Multivariate Prediction Model of the Clinical Progression of Alzheimer's Disease in a Community-Dwelling Multiethnic Cohort., J Alzheimers Dis, vol. 95, no. 1, pp. 93-117, 2023.
2022
X. - Y. He, Dobkin, C., W Brown, T., and Yang, S. - Y., 3-Hydroxyacyl-CoA and Alcohol Dehydrogenase Activities of Mitochondrial Type 10 17β-Hydroxysteroid Dehydrogenase in Neurodegeneration Study., J Alzheimers Dis, vol. 88, no. 4, pp. 1487-1497, 2022.
L. Chen, Shen, Q., Xu, S., Yu, H., Pei, S., Zhang, Y., He, X., Wang, Q. Z., and Li, D., 5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA as Diagnostic Biomarkers for Late-Onset Alzheimer's Disease., J Alzheimers Dis, vol. 85, no. 2, pp. 573-585, 2022.
I. Liampas, Hatzimanolis, A., Siokas, V., Yannakoulia, M., Kosmidis, M. H., Sakka, P., Hadjigeorgiou, G. M., Scarmeas, N., and Dardiotis, E., Antihypertensive Medication Class and the Risk of Dementia and Cognitive Decline in Older Adults: A Secondary Analysis of the Prospective HELIAD Cohort., J Alzheimers Dis, vol. 89, no. 2, pp. 709-719, 2022.
I. Liampas, Hatzimanolis, A., Siokas, V., Yannakoulia, M., Kosmidis, M. H., Sakka, P., Hadjigeorgiou, G. M., Scarmeas, N., and Dardiotis, E., Antihypertensive Medication Class and the Risk of Dementia and Cognitive Decline in Older Adults: A Secondary Analysis of the Prospective HELIAD Cohort., J Alzheimers Dis, vol. 89, no. 2, pp. 709-719, 2022.
O. Lerch, Pařízková, M., Vyhnálek, M., Nedelska, Z., Hort, J., and Laczó, J., APOEɛ4 Allele Moderates the Association Between Basal Forebrain Nuclei Volumes and Allocentric Navigation in Older Adults Without Dementia., J Alzheimers Dis, vol. 86, no. 1, pp. 155-171, 2022.
S. Mathew, WuDunn, D., Mackay, D. D., Vosmeier, A., Tallman, E. F., Deardorff, R., Harris, A., Farlow, M. R., Brosch, J. R., Gao, S., Apostolova, L. G., Saykin, A. J., and Risacher, S. L., Association of Brain Volume and Retinal Thickness in the Early Stages of Alzheimer's Disease., J Alzheimers Dis, vol. 91, no. 2, pp. 743-752, 2022.

Pages